NCT05433753View on ClinicalTrials.gov

Asian Multicenter Prospective Study in HER2 Positive Early Breast Cancer for Detecting MRD by ctDNA;HARMONY Study

RecruitingOBSERVATIONAL

Enrollment

60

Participants

Timeline

Start Date

May 24, 2022

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions

HER2-positive Breast Cancer

Trial Locations (1)

104-0045

RECRUITING

National Cancer Center Hospital, Japan, Chuo-ku

All Listed Sponsors

lead

National Cancer Center, Japan

OTHER_GOV